1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. (April 2019) Authors: Gupta, Rohan; Amanam, Idoroenyi; Rahmanuddin, Syed; Mambetsariev, Isa; Wang, Yingyu; Huang, Charity; Reckamp, Karen; Vora, Lalit; Salgia, Ravi Journal: American journal of clinical oncology Issue: Volume 42:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors. (August 2020) Authors: Zhao, Dan; Mambetsariev, Isa; Li, Haiqing; Chen, Chen; Fricke, Jeremy; Fann, Patricia; Kulkarni, Prakash; Xing, Yan; Lee, Peter P.; Bild, Andrea; Massarelli, Erminia; Koczywas, Marianna; Reckamp, Karen; Salgia, Ravi Journal: Lung cancer Issue: Volume 146(2020) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparative efficacy of brigatinib versus ceritinib and alectinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small cell lung cancer. (3rd April 2019) Authors: Reckamp, Karen; Lin, Huamao M.; Huang, Joice; Proskorovsky, Irina; Reichmann, William; Krotneva, Stanimira; Kerstein, David; Huang, Hui; Lee, Joseph Journal: Current medical research and opinion Issue: Volume 35:Number 4(2019) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. (22nd September 2021) Authors: Do, Khanh T.; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E.; Burris, Howard; Robert, Francisco; Camidge, D. Ross; Steuer, Conor E.; Strickler, John H.; Weise, Amy; Specht, Jennifer M.; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A. Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors. (22nd September 2021) Authors: Do, Khanh T.; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E.; Burris, Howard; Robert, Francisco; Camidge, D. Ross; Steuer, Conor E.; Strickler, John H.; Weise, Amy; Specht, Jennifer M.; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A. Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer. Issue 2 (28th July 2021) Authors: Liu, Bing; Duenas, Daniela; Zheng, Li; Reckamp, Karen; Shen, Binghui Journal: Protein & cell Issue: Volume 13:Issue 2(2022) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?. Issue 1 (December 2017) Authors: Guillon, Antoine; Reckamp, Karen; Heuzé-Vourc'h, Nathalie Journal: Critical care Issue: Volume 21:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗